Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT00297011
- Phase
- PHASE2
- Status
- Completed
Conditions
- Herpes Labialis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- valacyclovir+clobetasol gel — DRUG
Study Details
A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
Key Dates
- Start date
- Sep 30, 2004
- Status verified
- Apr 2008
- Primary completion
- Mar 31, 2007
- Completion
- Jan 31, 2008
Study Design
- Enrollment
- 300 participants
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
The primary efficacy variable is the maximum size of the primary lesion complex
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Utah | Salt Lake City | Utah | 84132 | - |
Find similar trials in Salt Lake City, UT
By research site
Related Studies
- Viral Infections in Healthy and Immunocompromised HostsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland